Applied BioCode Corp
TWSE:6598
Applied BioCode Corp
TWSE:6598
Price:
23.55
TWD
-2.48%
Market Closed
Market Cap:
NT$2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Applied BioCode Corp
TWSE:6598
|
TW |
|
Summerway Capital PLC
LSE:SWC
|
UK |
|
Maxigen Biotech Inc
TWSE:1783
|
TW |
|
BGF Retail Co Ltd
KRX:282330
|
KR |
Cash Flow Statement
Cash Flow Statement
Applied BioCode Corp
Applied BioCode Corp
Currency: TWD
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||
| Net Income |
(280)
|
(250)
|
(254)
|
(208)
|
(103)
|
(83)
|
(54)
|
(92)
|
(165)
|
(215)
|
(192)
|
(175)
|
(185)
|
(161)
|
(190)
|
(190)
|
(163)
|
(177)
|
(165)
|
(199)
|
(261)
|
(233)
|
(251)
|
(208)
|
(201)
|
|
| Depreciation & Amortization |
33
|
37
|
39
|
42
|
44
|
46
|
48
|
49
|
51
|
52
|
53
|
54
|
57
|
58
|
60
|
62
|
63
|
63
|
63
|
62
|
61
|
62
|
61
|
56
|
56
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
14
|
16
|
18
|
20
|
9
|
8
|
8
|
9
|
8
|
8
|
7
|
6
|
6
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
0
|
|
| Other Non-Cash Items |
12
|
11
|
15
|
15
|
(14)
|
(13)
|
(18)
|
(17)
|
14
|
13
|
13
|
10
|
2
|
(3)
|
(10)
|
(15)
|
(15)
|
(21)
|
(22)
|
(23)
|
(28)
|
(25)
|
(26)
|
(23)
|
(18)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
7
|
8
|
9
|
7
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
|
| Change in Working Capital |
(78)
|
(44)
|
(41)
|
(95)
|
(73)
|
(72)
|
(105)
|
1
|
(52)
|
7
|
244
|
252
|
272
|
226
|
(15)
|
(52)
|
(89)
|
(88)
|
(63)
|
(55)
|
20
|
(22)
|
(49)
|
(50)
|
(63)
|
|
| Cash from Operating Activities |
(314)
N/A
|
(246)
+22%
|
(241)
+2%
|
(247)
-3%
|
(147)
+41%
|
(121)
+17%
|
(129)
-7%
|
(59)
+54%
|
(152)
-156%
|
(143)
+6%
|
118
N/A
|
141
+19%
|
146
+4%
|
121
-17%
|
(156)
N/A
|
(195)
-25%
|
(205)
-5%
|
(222)
-8%
|
(187)
+16%
|
(214)
-15%
|
(208)
+3%
|
(220)
-6%
|
(266)
-21%
|
(226)
+15%
|
(227)
0%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||
| Capital Expenditures |
(24)
|
(36)
|
(40)
|
(38)
|
(28)
|
(17)
|
(16)
|
(22)
|
(16)
|
(16)
|
(12)
|
(18)
|
(22)
|
(26)
|
(25)
|
(13)
|
(6)
|
(4)
|
(4)
|
(6)
|
(7)
|
(7)
|
(8)
|
(7)
|
(9)
|
|
| Other Items |
(122)
|
(112)
|
140
|
(123)
|
115
|
0
|
(7)
|
255
|
(0)
|
0
|
0
|
0
|
0
|
(184)
|
(190)
|
(199)
|
(192)
|
111
|
114
|
124
|
(52)
|
(73)
|
(79)
|
(36)
|
136
|
|
| Cash from Investing Activities |
(146)
N/A
|
(149)
-2%
|
100
N/A
|
(161)
N/A
|
87
N/A
|
98
+13%
|
(23)
N/A
|
234
N/A
|
(16)
N/A
|
(16)
+5%
|
(12)
+23%
|
(18)
-53%
|
(22)
-21%
|
(210)
-849%
|
(215)
-2%
|
(212)
+1%
|
(198)
+7%
|
107
N/A
|
110
+3%
|
118
+7%
|
(59)
N/A
|
(80)
-35%
|
(87)
-9%
|
(42)
+52%
|
128
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||
| Net Issuance of Common Stock |
391
|
391
|
1 093
|
752
|
705
|
705
|
4
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
441
|
441
|
441
|
441
|
0
|
0
|
|
| Net Issuance of Debt |
49
|
(15)
|
(111)
|
(169)
|
(48)
|
(47)
|
(14)
|
(13)
|
(16)
|
(17)
|
(17)
|
(17)
|
(15)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(18)
|
(19)
|
(19)
|
|
| Cash from Financing Activities |
439
N/A
|
376
-14%
|
982
+161%
|
583
-41%
|
657
+13%
|
658
+0%
|
(11)
N/A
|
(10)
+2%
|
(14)
-36%
|
(16)
-11%
|
(16)
-2%
|
(17)
-5%
|
(15)
+12%
|
(15)
+1%
|
(15)
-5%
|
(16)
-2%
|
(16)
0%
|
(16)
-1%
|
(16)
-2%
|
425
N/A
|
424
0%
|
423
0%
|
423
+0%
|
(19)
N/A
|
(19)
+1%
|
|
| Change in Cash | ||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(25)
|
(34)
|
(27)
|
(66)
|
(51)
|
(43)
|
(56)
|
(39)
|
(19)
|
3
|
50
|
98
|
76
|
46
|
31
|
5
|
1
|
29
|
23
|
(17)
|
35
|
22
|
(32)
|
(8)
|
(23)
|
|
| Net Change in Cash |
(46)
N/A
|
(53)
-14%
|
814
N/A
|
110
-87%
|
545
+397%
|
591
+8%
|
(218)
N/A
|
125
N/A
|
(202)
N/A
|
(172)
+15%
|
140
N/A
|
203
+45%
|
185
-9%
|
(57)
N/A
|
(355)
-518%
|
(418)
-18%
|
(418)
0%
|
(101)
+76%
|
(70)
+31%
|
311
N/A
|
193
-38%
|
146
-24%
|
39
-73%
|
(294)
N/A
|
(141)
+52%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||
| Free Cash Flow |
(338)
N/A
|
(282)
+16%
|
(281)
+1%
|
(285)
-2%
|
(175)
+39%
|
(138)
+21%
|
(146)
-5%
|
(81)
+44%
|
(168)
-108%
|
(159)
+6%
|
107
N/A
|
122
+15%
|
124
+1%
|
95
-23%
|
(181)
N/A
|
(208)
-15%
|
(211)
-2%
|
(225)
-6%
|
(192)
+15%
|
(220)
-15%
|
(215)
+2%
|
(227)
-5%
|
(274)
-21%
|
(233)
+15%
|
(235)
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
